Agilent Technologiesvs.Revvity
A vs RVTY · both in Life science tools, part of the Medicine, pharma & life science value chain: Instruments, reagents and equipment for research, development and production.
Agilent Technologies is about 3.0× larger than Revvity by market cap; Agilent Technologies trades at the lower P/E (26.8 vs 52.6); year to date, Revvity leads (+16.1% vs −1.3%).
Side by side
| A | RVTY | |
|---|---|---|
| Market cap | $37.9B | $12.6B |
| Price | $134.29 | $112.29 |
| Today | +0.5% | −0.6% |
| Return YTD | −1.3% | +16.1% |
| Return 1Y | +8.2% | +9.7% |
| P/E | 26.8 | 52.6 |
| P/S | 5.2 | 4.3 |
| P/B | 5.3 | 1.8 |
Data as of 2026-07-11 · updates daily after U.S. close
The two companies
Agilent TechnologiesA
American manufacturer of analytical instruments and laboratory solutions for life science, diagnostics and chemical analysis.
Full A profile →RevvityRVTY
Life science tools and diagnostics across newborn screening and research.
Full RVTY profile →More comparisons in Life science tools
See where A and RVTY sit in the full Medicine, pharma & life science map — every segment from suppliers to end markets.Open the Life science value chain →